Startup companies
fromHarvard Gazette
3 months agoHarvard startup creating a new class of antibiotics - Harvard Gazette
Kinvard Bio aims to tackle antibiotic resistance by developing a new class of antibiotics to treat infections effectively.
#biotechnology
#biotechnology
[ follow ]
#funding
Cancer
fromNon Profit News | Nonprofit Quarterly
1 month agoCancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly
The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.
Cancer
fromNon Profit News | Nonprofit Quarterly
1 month agoCancer Research in the US Is World Class Because of Its Broad Base of Funding-with the Government Pulling Out, Its Future Is Uncertain - Non Profit News | Nonprofit Quarterly
The complex ecosystem of U.S. cancer research is threatened by funding instability and political shifts.
#genetics
OMG science
fromNature
3 months agoMeet the 'woolly mouse': why scientists doubt it's a big step towards recreating mammoths
Colossal Biosciences announces breakthrough with genetic manipulation of mice, aimed at de-extincting woolly mammoths.
Startup companies
fromThe Washington Post
2 months ago23andMe thought its DNA data would help research. Then reality hit.
23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.
CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.
Startup companies
fromThe Washington Post
2 months ago23andMe thought its DNA data would help research. Then reality hit.
23andMe's decline from a $6 billion valuation culminated in Chapter 11 bankruptcy amid unsuccessful business ventures and market challenges.
CEO Anne Wojcicki resigned but expressed continued belief in the company's potential.
#artificial-intelligence
Artificial intelligence
fromNature
3 months agoFour ways to power-up AI for drug discovery
AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.
Startup companies
fromFast Company
2 months agoThese 10 biotech companies are changing how we discover new drugs and treat complex diseases
Biotech companies are harnessing AI and cutting-edge research tools to enhance drug development and diagnostics.
#investment
NYC startup
fromBusiness Insider
3 months agoA startup plans to make money from reviving the woolly mammoth. Here's how.
Colossal Biosciences aims to revive extinct species, leveraging advancements in biotechnology to create new revenue streams and innovations.
European startups
fromSilicon Canals
3 months agoUK's Epoch Biodesign secures 17.1M in Series A
Epoch Biodesign raised $18.3M to enhance enzyme technology for improved plastic recycling over traditional methods.
#immunology
Coronavirus
fromCornell Chronicle
3 months agoCOVID-flu vaccine could provide broad, lasting protection | Cornell Chronicle
A new vaccine platform from Cornell researchers offers longer-lasting protection against COVID-19 and influenza, showing promising results in mouse models.
Alternative medicine
fromwww.mercurynews.com
1 month agoBay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment
Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.
Alternative medicine
fromwww.mercurynews.com
1 month agoBay Area man who injected himself with venom hundreds of times could revolutionize snakebite treatment
Tim Friede's unique exposure to snake venom has led to the development of an antivenom for 19 snake species, showcasing new possibilities in snakebite treatment.
fromSilicon Canals
1 month agoBelfast-based AMPLY Discovery completes 1.5M seed funding
Ten years ago, I began combining financial modeling expertise with computational biology to create a drug discovery platform. Evolution has spent billions of years perfecting natural defence mechanisms, and now we're using AI to unlock this wisdom.
London startup
#de-extinction
OMG science
fromFast Company
2 months agoColossal says creating woolly mice is a 'validation step' for de-extinction and could help eradicate diseases
Colossal Biosciences achieved a milestone by genetically engineering woolly mice, marking a significant step towards woolly mammoth de-extinction.
OMG science
fromInsideHook
3 months agoHave Scientists Created Hybrids of Mice and Mammoths?
Colossal's latest project involves gene-edited mice simulating wooly mammoth traits, raising questions about de-extinction efforts.
OMG science
fromwww.scientificamerican.com
3 months agoCompany Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'
Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
OMG science
fromwww.theguardian.com
3 months agoScientists aiming to bring back woolly mammoth create woolly mice
Scientists create genetically modified woolly mice as a step toward reviving woolly mammoths.
OMG science
fromwww.scientificamerican.com
3 months agoCompany Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'
Colossal Biosciences introduces lab-created woolly mice as a step toward reviving extinct species, emphasizing genetic engineering's role in enhancing resilience against climate change.
#gene-editing
European startups
fromTNW | Deep-Tech
3 months agoTech firms are cashing in on the bizarre science of organ preservation
The evolution of organ transplantation technology is creating new business opportunities.
OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.
Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.
European startups
fromTNW | Deep-Tech
3 months agoTech firms are cashing in on the bizarre science of organ preservation
The evolution of organ transplantation technology is creating new business opportunities.
OrganOx's innovative liver preservation technology enhances transplant success rates by extending organ viability.
Xenotransplantation using gene-edited pig organs is emerging as a solution for organ shortages.
[ Load more ]